Tamsulosin Hydrochloride

DRUG19 trials

Sponsors

Vanderbilt University, Boehringer Ingelheim, Astellas Pharma Inc, Mayo Clinic, Astellas Pharma Global Development, Inc.

Conditions

BPHBenign Prostatic HyperplasiaBenign Prostatic HypertrophyBladder Outlet ObstructionBladder, NeurogenicChronic ProstatitisChronic Prostatitis With Chronic Pelvic Pain SyndromeHypertension

Phase 1

Treatment of Supine Hypertension in Autonomic Failure

CompletedNCT00223717

Vanderbilt UniversityHypertension

Start: 2001-01-31End: 2017-01-31Updated: 2017-10-13

Phase 2

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

CompletedNCT00340704

Boehringer IngelheimBladder, Neurogenic

Start: 2006-04-30End: 2009-06-30Updated: 2016-02-17

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

CompletedNCT00507455

Astellas Pharma IncBladder Outlet Obstruction, Lower Urinary Tract Symptoms

Start: 2007-06-30End: 2008-08-31Updated: 2014-08-06

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH

CompletedNCT00510406

Astellas Pharma IncLower Urinary Tract Symptoms, Prostatic Hyperplasia

Start: 2007-01-31End: 2007-09-30Updated: 2014-08-20

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

CompletedNCT00796614

Boehringer IngelheimBladder, Neurogenic

Start: 2008-01-31End: 2009-02-28Updated: 2015-10-29

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

CompletedNCT02244281

Boehringer IngelheimLower Urinary Tract Symptoms

Start: 2001-05-31Updated: 2014-09-19

Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin

CompletedNCT04552431

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Start: 1997-09-30End: 2003-08-31Updated: 2020-09-18

Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial

RecruitingNCT06262048

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sUrinary Retention Postoperative

Start: 2024-10-01End: 2026-02-01Target: 60Updated: 2024-10-28

Phase 3

Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

TerminatedNCT01568918

Mayo ClinicPostoperative Urinary Retention

Start: 2012-05-31End: 2019-11-21Updated: 2024-05-30

Actual Use Study of Tamsulosin in Men

CompletedNCT02573311

Boehringer IngelheimUrological Manifestations

Start: 2015-09-23End: 2016-08-01Updated: 2020-04-08

REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial

McMaster UniversityThoracic Epidural Analgesia, Thoracic Surgery, Urinary Catheterization

Start: 2021-07-30End: 2023-12-31Target: 350Updated: 2021-02-25

Phase 4

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

CompletedNCT00771394

Astellas Pharma IncBenign Prostatic Hyperplasia, Benign Prostatic Hypertrophy, Overactive Bladder

Start: 2008-10-31End: 2010-01-31Updated: 2013-02-15

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

CompletedNCT02244242

Boehringer IngelheimProstatic Hyperplasia

Start: 1998-07-31Updated: 2014-09-19

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

CompletedNCT02757768

Astellas Pharma Global Development, Inc.Benign Prostatic Hyperplasia, Overactive Bladder

Start: 2016-06-13End: 2018-09-11Updated: 2024-11-12

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH

NeoTract, Inc.BPH

Start: 2021-12-06End: 2025-10-31Target: 250Updated: 2023-04-25

Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin

TerminatedNCT04994431

University of Massachusetts, WorcesterThoracic Diseases, Urinary Retention

Start: 2021-08-01End: 2023-10-04Updated: 2024-11-07

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

CompletedNCT05890235

Xintian PharmaceuticalChronic Prostatitis

Start: 2018-11-16End: 2022-07-10Updated: 2023-06-06

Unknown Phase

Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy

RecruitingNCT06865430

Ankara Training and Research HospitalProstate Hyperplasia

Start: 2025-03-04End: 2026-03-04Target: 82Updated: 2025-03-24

The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia

RecruitingNCT06867315

First Affiliated Hospital of Zhejiang UniversityBenign Prostatic Hyperplasia

Start: 2024-05-29End: 2026-05-29Target: 10Updated: 2025-03-10

Related Papers

Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study.

2025-12-03

Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.

2014-11-067 citations

Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).

2013-03-1951 citations